IBC
Source: WCG
Since 2000, WCG has provided personalized Institutional Biosafety Committee (IBC) services and streamlined processes to over 800 institutions comprising hundreds of actives sites around the world.
Since 2000, WCG has provided Institutional Biosafety Committee (IBC) services to over 800 institutions comprising hundreds of actives sites around the world. Our team has evaluated more than 400 human gene transfer protocols – more than any other organization outside of the FDA and NIH. Our experience personalized service, and streamlined processes makes us the premier partner for IBC administration and review.
This website uses cookies to ensure you get the best experience on our website. Learn more